Biomarkers in Brain Disease
41 – 50 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation
(
- Contribution to journal › Article
-
Mark
Flt3 ligand does not differentiate between Parkinsonian disorders.
(
- Contribution to journal › Article
-
Mark
A porous silicon immunoassay platform for fluorometric determination of alpha-synuclein in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Skeletal muscle atrophy in r6/2 mice - altered circulating skeletal muscle markers and gene expression profile changes.
(
- Contribution to journal › Article
-
Mark
Plasma Melatonin Is Reduced in Huntington's Disease
(
- Contribution to journal › Article
- 2013
-
Mark
JAK/STAT Signalling in Huntington's Disease Immune Cells.
(
- Contribution to journal › Article
-
Mark
A Critical Evaluation of Inflammatory Markers in Huntington’s Disease Plasma
(
- Contribution to journal › Article
- 2012
-
Mark
No diagnostic value of plasma clusterin in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease.
2012) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 32(1). p.133-142(
- Contribution to journal › Article